Federated Hermes’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $45.9K | Sell |
|
|||||
|
2024
Q3 | $1.25M | Buy |
|
|||||
|
2024
Q2 | $133K | Sell |
|
|||||
|
2024
Q1 | $85.4K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $6.01K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $36.3M | Hold |
|
|||||
|
2022
Q4 | $52.4M | Sell |
|
|||||
|
2022
Q3 | $40.5M | Buy |
|
|||||
|
2022
Q2 | $36M | Hold |
|
|||||
|
2022
Q1 | $45.7M | Hold |
|
|||||
|
2021
Q4 | $58.8M | Sell |
|
|||||
|
2021
Q3 | $61M | Buy |
|
|||||
|
2021
Q2 | $48.7M | Buy |
|
|||||
|
2021
Q1 | $39.3M | Buy |
|
|||||
|
2020
Q4 | $36.5M | Buy |
|
|||||
|
2020
Q3 | $35.9M | Buy |
|
|||||
|
2020
Q2 | $10.5M | Buy |
|